C12Y 301/01048
Fusarinine-c ornithinesterase
Official title: Fusarinine-C ornithinesterase (3.1.1.48)
C12Y301/01048 (Fusarinine-c ornithinesterase) appears on 7 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 8
- Assignees
- 4
- Inventors
- 9
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 2 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Genetically encoded system for constructing and detecting biologically active agents13 May 2025US 12,297,234 B2The Regents of the University of Colorado, a body corporate
- Genetically encoded system for constructing and detecting biologically active agents28 May 2024US 11,993,635 B2The Regents of the University of Colorado, a body corporate
- Genetically encoded system for constructing and detecting biologically active agents18 Oct 2022US 11,472,847 B2The Regents of the University of Colorado
- Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin26 Nov 2019US 10,488,410 B2RSR Limited
- Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin19 Nov 2019US 10,481,156 B2RSR Limited
- Genetically encoded system for constructing and detecting biologically active agents20 Jun 2024US 2024/0199704 A1The Regents of the University of Colorado, a body corporate
- Method for preparing a composition comprising an unfolded protein23 Nov 2023US 2023/0372450 A1Linnane Pharma AB
- Genetically encoded system for constructing and detecting biologically active agents18 May 2023US 2023/0151062 A1The Regents of the University of Colorado, a body corporate
- Genetically encoded system for constructing and detecting biologically active agents8 Jul 2021US 2021/0206813 A1The Regents of the University of Colorado, a body corporate
- Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin8 Dec 2016US 2016/0356771 A1RSR Limited
Most cited
By later US patents
- Genetically encoded system for constructing and detecting biologically active agents3US 11,472,847 B2The Regents of the University of Colorado · 2022
- Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin3US 8,129,132 B2RSR Limited · 2012
- Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin2US 9,435,797 B2RSR Limited · 2016
- Genetically encoded system for constructing and detecting biologically active agents1US 11,993,635 B2The Regents of the University of Colorado, a body corporate · 2024